These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 20228226)

  • 21. Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.
    Akamata K; Asano Y; Taniguchi T; Yamashita T; Saigusa R; Nakamura K; Noda S; Aozasa N; Toyama T; Takahashi T; Ichimura Y; Sumida H; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2015 Jul; 54(7):1308-16. PubMed ID: 25539827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.
    Asano Y
    Med Mol Morphol; 2015 Sep; 48(3):123-8. PubMed ID: 25986681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
    Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
    Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.
    Takahashi T; Asano Y; Sugawara K; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Toyama T; Taniguchi T; Akamata K; Noda S; Yoshizaki A; Tsuruta D; Trojanowska M; Sato S
    J Exp Med; 2017 Apr; 214(4):1129-1151. PubMed ID: 28232470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
    Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
    Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis.
    Ichimura Y; Asano Y; Akamata K; Takahashi T; Noda S; Taniguchi T; Toyama T; Aozasa N; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
    Arch Dermatol Res; 2014 May; 306(4):331-8. PubMed ID: 24292093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.
    Trojanowska M
    Nat Rev Rheumatol; 2010 Aug; 6(8):453-60. PubMed ID: 20585340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Miura S; Toyama T; Takahashi T; Ichimura Y; Yoshizaki A; Trojanowska M; Sato S
    J Invest Dermatol; 2017 Mar; 137(3):631-640. PubMed ID: 27777101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.
    Asano Y; Bujor AM; Trojanowska M
    J Dermatol Sci; 2010 Sep; 59(3):153-62. PubMed ID: 20663647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.
    Saigusa R; Asano Y; Taniguchi T; Hirabayashi M; Nakamura K; Miura S; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Trojanowska M; Sato S
    Arthritis Res Ther; 2018 Feb; 20(1):23. PubMed ID: 29415756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis.
    Yamashita K; Kawasaki A; Matsushita T; Furukawa H; Kondo Y; Okiyama N; Nagaoka S; Shimada K; Sugii S; Katayama M; Hirohata S; Okamoto A; Chiba N; Suematsu E; Setoguchi K; Migita K; Sumida T; Tohma S; Hamaguchi Y; Hasegawa M; Sato S; Kawaguchi Y; Takehara K; Tsuchiya N
    Rheumatology (Oxford); 2020 Nov; 59(11):3553-3562. PubMed ID: 32696043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.
    Taniguchi T; Asano Y; Akamata K; Noda S; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
    Arthritis Rheumatol; 2015 Feb; 67(2):517-26. PubMed ID: 25385187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.
    Kubo M; Czuwara-Ladykowska J; Moussa O; Markiewicz M; Smith E; Silver RM; Jablonska S; Blaszczyk M; Watson DK; Trojanowska M
    Am J Pathol; 2003 Aug; 163(2):571-81. PubMed ID: 12875977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a /FLI1 axis.
    Cheng Z; Zhang J; Deng W; Lin S; Li D; Zhu K; Qi Q
    Bioengineered; 2021 Dec; 12(1):1212-1225. PubMed ID: 33843426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma.
    Miura S; Watanabe Y; Saigusa R; Yamashita T; Nakamura K; Hirabayashi M; Miyagawa T; Yoshizaki A; Trojanowska M; Sato S; Asano Y
    Arthritis Res Ther; 2021 May; 23(1):137. PubMed ID: 33964960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.
    Miyagawa T; Asano Y; Saigusa R; Hirabayashi M; Yamashita T; Taniguchi T; Takahashi T; Nakamura K; Miura S; Yoshizaki A; Miyagaki T; Sato S
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):753-760. PubMed ID: 30520152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.
    Bujor AM; Haines P; Padilla C; Christmann RB; Junie M; Sampaio-Barros PD; Lafyatis R; Trojanowska M
    Int J Mol Med; 2012 Dec; 30(6):1473-80. PubMed ID: 23041765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.